Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Oncology, Basic Science Track

  • You have access
    PARP1 as a molecular target for the delivery of theranostic Auger emitters to cancer chromatin
    Mehran MaKvandi, Harrison Winters, Chi-Chang Weng, Laura Puentes, Chia-Ju Hsieh, David Mankoff, Daniel Pryma and Robert Mach
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 59;
  • You have access
    Safety, Pharmacokinetics and Dosimetry of a Long-lasting Radiolabeled Somatostatin Analogue 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors: A Phase 1 First-in-human Study
    Jingjing Zhang, Gang Niu, Hao Wang, Orit Jacobson, Yuejuan Cheng, Jie Zang, Fang Li, Chunmei Bai, Zhaohui Zhu and Xiaoyuan Chen
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 118;
  • You have access
    Precision Bone PET imaging: Ultra-high definition image reconstruction enabled by digital PET/CT in a pre-clinical canine model
    Maria Menendez, Richard Moore, Katherine Binzel, Michael Friel, Jun Zhang and Michael Knopp
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1284;
  • You have access
    Characterization of tumor-associated neovasculature in HCC
    Olga Sergeeva, Yifan Zhang, Maxim Sergeev, Wuxian Shi, Sandra Sexton, Renuka Iyer, James Basilion, Norbert Avril and Zhenghong Lee
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1274;
  • You have access
    Species difference of astatine-211 uptakes in the whole body distribution: preclinical study using treated At-solution.
    Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuwei Liu, Yoshifumi Shirakami, Atsushi Toyoshima, Mitsuaki Tatsumi, Eku Shimosegawa, Mitsuhiro Fukuda, Atsushi Shinohara and Jun Hatazawa
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1269;
  • You have access
    Preclinical Monitoring of Therapeutic Response of Dual Targeted Hyaluronic Acid Nanodrug with PET/CT
    Qingjie Ma and Minglong Chen
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 242;
  • You have access
    Pre-clinical individualized dosimetry of iron-oxide nanoparticle based 177Lu-labelled folate conjugates targeted SPECT/CT imaging
    Arun Gupta, Min Sun Lee, Jae Hwan Shin, Ji Yong Park, Joong Hyun Kim, Cho Rong Park, Young Ju Kim, Myung Geun Song, Yun-Sang Lee, Jae Min Jeong, Dong Soo Lee and Jae Sung Lee
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 317;
  • You have access
    Targeting VPAC1 receptors for imaging glioblastoma
    Sushil Tripathi, Rhonda Kean, D. Craig Hooper, Yuan Yuan Jin, Eric Wickstrom and Mathew Thakur
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1262;
  • You have access
    Radioiodine therapy oflung cancer following targeting expression of thesodium iodide symporter induced by midkine promoter
    Da Mu
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1296;
  • You have access
    PET imaging of gonadotropin releasing hormone receptor expression using [18F]-labeled GnRH peptide
    Kongzhen Hu
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1291;

Pages

  • Previous
  • Next
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 50
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire